Sign inJoin waitlistJoin the waitlist

Barbara Goff

Chair, Department of Obstetrics & Gynecology, UW Medicine · University of Washington School of Medicine

Credentials: · · · ·

History

Department of Obstetrics & Gynecology · University of Washington School of Medicine
Present
UW Medical Center Division · University of Washington School of Medicine
Present
Obstetrics &… Department · University of Washington School of Medicine
Present

Gynecologic Oncology
Massachusetts General Hospital
1990–1993
Obstetrics and Gynecology
Brigham and Women's Hospital
1986–1990
Perelman School of Medicine at the University of Pennsylvania
1982–1986

Research

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian,…
Journal of Clinical Oncology · 2012 · 1,048 citations
Frequency of symptoms of ovarian cancer in women presenting to primary care clinics
JAMA · 2004 · First of 4 authors · Corresponding · 310 citations
Ovarian carcinoma diagnosis
Cancer · 2000 · First of 4 authors · 309 citations

HM
Howard Muntz
30 papers
Elizabeth Swisher
29 papers · 4 as a fellow
Heidi Gray
26 papers · 1 as a fellow
Rochelle Garcia
25 papers
Hisham Tamimi
24 papers
LR
Laurel Rice
17 papers · 1 as a resident
PP
Pamela Paley
17 papers · 11 as a fellow
Renata Urban
17 papers · 1 as a fellow
Laura-Mae Baldwin
12 papers
Gretchen Lentz
11 papers
AF
Arlan Fuller
10 papers
Chirag Shah
10 papers · 8 as a resident

Grants

Women's Reproductive Health Research at the University of Washington
National Institute of Child Health and Human Development · K12
Contact PI · $3.3M · University of Washington
1998–2030

Clinical trials

Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Principal investigator · Completed · Phase 2
University of Washington
2006
Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Principal investigator · Completed · Phase 2
Fred Hutchinson Cancer Center
2002